Cargando…
Emerging Lung Cancer Therapeutic Targets Based on the Pathogenesis of Bone Metastases
Lung cancer is the second most common cancer and the leading cause of cancer related mortality in both men and women. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined. It is widely accepted that tumor metastasis is a formidable barrier to effective treat...
Autores principales: | Oyewumi, Moses O., Alazizi, Adnan, Wehrung, Daniel, Manochakian, Rami, Safadi, Fayez F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147348/ https://www.ncbi.nlm.nih.gov/pubmed/25197279 http://dx.doi.org/10.1155/2014/236246 |
Ejemplares similares
-
Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells
por: Oyewumi, Moses O., et al.
Publicado: (2016) -
Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
por: Li, Shenduo, et al.
Publicado: (2023) -
Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020) -
Efficacy assessment of methylcellulose-based thermoresponsive hydrogels loaded with gallium acetylacetonate in osteoclastic bone resorption
por: Ghanta, Pratyusha, et al.
Publicado: (2023) -
Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
por: Majeed, Umair, et al.
Publicado: (2021)